É. Lepage

发表

A clinical decision support system for prevention of venous thromboembolism: effect on physician behavior.

P. Ravaud, É. Lepage, P. Durieux, 2000, JAMA.

p53 gene mutations are associated with poor survival in low and low-intermediate risk diffuse large B-cell lymphomas.

P. Gaulard, G. Salles, F. Berger, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

A predictive model for aggressive non-Hodgkin's lymphoma.

Emili Montserrat, Christian Gisselbrecht, Carlo Tondini, 1993, The New England journal of medicine.

Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study

Corinne Alberti, Antonio Artigas, Ronan Boulmé, 2002, Intensive Care Medicine.

Autologous bone marrow transplantation in Hodgkin's disease.

C. Gisselbrecht, M. Boiron, É. Lepage, 1990, Nouvelle revue francaise d'hematologie.

Mortality prediction using SAPS II: an update for French intensive care units

François Hemery, J. le Gall, D. Villers, 2005, Critical care.

An Intranet-Based Automated System for the Surveillance of Nosocomial Infections: Prospective Validation Compared with Physicians' Self-Reports

Harry C. Karadimas, Samir Bouam, Emmanuelle Girou, 2003, Infection Control & Hospital Epidemiology.

Prognostic significance of survivin expression in diffuse large B-cell lymphomas.

J Diebold, T. Molina, P. Gaulard, 2000, Blood.

Model-Based Methodology for Analyzing Incomplete Quality-of-Life Data and Integrating Them into the Q-Twist Framework

N. Mounier, É. Lepage, H. Flechtner, 2003, Medical decision making : an international journal of the Society for Medical Decision Making.

Combined chemotherapy-radiotherapy in advanced Hodgkin's disease: results of a prospective clinical trial with 70 stage IIIB-IV patients.

C. Gisselbrecht, C. Fermé, M. Marty, 1993, International journal of radiation oncology, biology, physics.

Tumour necrosis factor-α, interleukin-1β and interleukin-6 in patients with renal cell carcinoma

É. Lepage, J. Cabane, C. Dosquet, 1994 .

Expanding the nurse's role to improve preventive service in an outpatient clinic.

É. Lepage, J. Hoey, H. McCallum, 1982, Canadian Medical Association journal.

Mediastinal lymphoma: quantitative changes in gadolinium enhancement at MR imaging after treatment.

P. Gaulard, A. Rahmouni, É. Lepage, 2001, Radiology.

Effects of erythropoietin (rHuEpo) plus granulocyte colony stimulating factor (rHuG-CSF) for the treatment of myelodysplastic syndromes (MDS) on anemia, costs and quality of life: a randomized controlled trial.

A. Stamatoullas, A. Vekhoff, P. Durieux, 2004 .

Feasibility of tandem autologous stem-cell transplantation (ASCT) in induction failure or very unfavorable (UF) relapse from Hodgkin's disease (HD). SFGM/GELA Study Group.

B. Coiffier, P. Rohrlich, É. Lepage, 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

The MINE regimen as intensive salvage chemotherapy for relapsed and refractory Hodgkin's disease.

F. Berger, É. Lepage, P. Morel, 1995, Annals of oncology : official journal of the European Society for Medical Oncology.

Surgical restaging of advanced Hodgkin's disease after first line chemotherapy

É. Lepage, P. Brice, J. Fermand, 1991, European journal of haematology.

Human immunodeficiency virus-related lymphoma treatment with intensive combination chemotherapy

B. Coiffier, É. Oksenhendler, C. Gisselbrecht, 1993 .

Autologous hematopoietic stem cell transplantation in intermediate and high grade non-Hodgkin's lymphoma: a review.

B. Coiffier, H. Tilly, C. Gisselbrecht, 1993, Annals of oncology : official journal of the European Society for Medical Oncology.

Bone marrow histological patterns can predict survival of patients with grade 1 or 2 follicular lymphoma: a study from the Groupe d‘Etude des Lymphomes Folliculaires

L. Xerri, N. Brousse, É. Lepage, 2004, British journal of haematology.

Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98 Groupe d'Etude des Lymphomes de l'Adulte programs.

P. Gaulard, B. Coiffier, H. Tilly, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Clinical Decision Support System for Prevention of Venous Thromboembolism

Philippe Ravaud, Pierre Durieux, Nicolas Mounier, 2013 .

High-dose therapy followed by stem cell transplantation in partial response after first-line induction therapy for aggressive non-Hodgkin's lymphoma.

P. Gaulard, B. Coiffier, H. Tilly, 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

Cyclophosphamide/mitoxantrone/melphalan (CMA) regimen prior to autologous bone marrow transplantation (ABMT) in metastatic breast cancer.

C. Gisselbrecht, É. Lepage, J. Lotz, 1996, Bone marrow transplantation.

Hematopoietic reconstitution after autologous blood stem cell transplantation: A report of 46 cases

G. Leverger, H. Tilly, É. Lepage, 1987 .

Low-grade stage III-IV follicular lymphoma: multivariate analysis of prognostic factors in 484 patients--a study of the groupe d'Etude des lymphomes de l'Adulte.

B. Coiffier, H. Tilly, N. Brousse, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Incidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkin's lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis: A GELA study on 974 patients

H. Tilly, É. Lepage, C. Haioun, 2000 .

Diagnostic value of dominant T-cell clones in peripheral blood in 363 patients presenting consecutively with a clinical suspicion of cutaneous lymphoma.

É. Lepage, L. Laroche, M. Bagot, 2000, Blood.

A multivariate analysis of the survival of patients with aggressive lymphoma: variations in the predictive value of prognostic factors during the course of the disease. Groupe d'Etudes des Lymphomes de l'Adulte.

B. Coiffier, H. Tilly, C. Gisselbrecht, 1998, Cancer.

Prognostic factors of acute non lymphoblastic leukemia in children and adults. Results from two multicentric trials (705 patients).

H. Tilly, S. Chevret, É. Lepage, 1990, Nouvelle revue francaise d'hematologie.

Adult lymphoblastic lymphoma: a retrospective analysis of 92 patients under 61 years included in the LNH87/93 trials

R. Bouabdallah, S. Leprêtre, C. Sebban, 2003, Leukemia.

Autologous peripheral blood stem cell transplantation after high dose therapy in patients with advanced lymphomas.

H. Dombret, A. Baruchel, C. Gisselbrecht, 1992, Bone marrow transplantation.

Prognosis of aggressive lymphomas: a study of five prognostic models with patients included in the LNH-84 regimen.

B. Coiffier, É. Lepage, 1989, Blood.

Results of three courses of adriamycin, bleomycin, vindesine, and dacarbazine with subtotal nodal irradiation in 189 patients with nodal Hodgkin's disease (stage I, II and IIIA).

C. Gisselbrecht, É. Lepage, M. André, 1997, Hematology and cell therapy.

Long-term kidney graft survival across a positive historic but negative current sensitized cross-match.

D. Chopin, P. Bierling, É. Lepage, 2002, Transplantation.

Is the small non-cleaved-cell lymphoma histologic subtype a poor prognostic factor in adult patients? A case-controlled analysis. The Groupe d'Etude des Lymphomes de l'Adulte.

B. Coiffier, H. Tilly, É. Lepage, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Diagnostic value of dominant T-cell clones in peripheral blood in 363 patients presenting consecutively with a clinical suspicion of cutaneous lymphoma

É. Lepage, L. Laroche, M. Bagot, 2000 .

[Cancer of the breast: intensive treatment with bone marrow autografts].

M. Espié, C. Gisselbrecht, M. Marty, 1989, Bulletin du cancer.

Advanced hodgkin disease with large mediastinal involvement can be treated with eight cycles of chemotherapy alone after a major response to six cycles of chemotherapy

F. Berger, É. Lepage, P. Brice, 2001, Cancer.

Surgical resection plus chemotherapy versus chemotherapy alone: comparison of two strategies to treat diffuse large B-cell gastric lymphoma.

É. Lepage, C. Haioun, A. Delmer, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Immunophenotype of adult acute lymphoblastic leukemia, clinical parameters, and outcome: an analysis of a prospective trial including 562 tested patients (LALA87). French Group on Therapy for Adult Acute Lymphoblastic Leukemia.

F. Sigaux, C. Sebban, M. Béné, 1994, Blood.

Prognostic significance of a polymerase chain reaction-detectable dominant T-lymphocyte clone in cutaneous lesions of patients with mycosis fungoides.

T. Petrella, É. Lepage, M. Bagot, 1998, Blood.

Normal spinal bone marrow in adults: dynamic gadolinium-enhanced MR imaging.

A. Rahmouni, S. Breil, É. Lepage, 2003, Radiology.

Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d'Etudes des Lymphomes de l'Adulte (GELA).

P. Gaulard, F. Berger, B. Coiffier, 1998, Blood.

Shortened first-line high-dose chemotherapy for patients with poor-prognosis aggressive lymphoma.

T. Molina, B. Coiffier, H. Tilly, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Shortened Firs t-Line High-Dose Chemotherapy for Pat ients With Poor-Prognosis Aggress ive Lymphoma

T. Molina, B. Coiffier, H. Tilly, 2002 .

A multivariate analysis of the survival of patients with aggressive lymphoma

B. Coiffier, H. Tilly, C. Gisselbrecht, 1998 .

Primary anaplastic large-cell lymphoma in adults: clinical presentation, immunophenotype, and outcome.

P. Gaulard, F. Berger, J. Diebold, 1997, Blood.

Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2. Groupe d'Etude des Lymphomes de l'Adulte.

P. Gaulard, B. Coiffier, H. Tilly, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Alternance of chemotherapy does not improve results in aggressive non-Hodgkin's lymphoma: A prospective randomized study on 884 patients LNH87 protocol group 3: A gela study

P. Gaulard, B. Coiffier, H. Tilly, 1996 .

Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?

É. Lepage, J. Cabane, C. Dosquet, 1997, Clinical Cancer Research.

Primary mediastinal large B-cell lymphoma. A clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphomas, a GELA ("Groupe d'Etude des Lymphomes de l'Adulte") study.

P. Gaulard, J. Diebold, P. Biron, 1996, The American journal of surgical pathology.

Prognostic significance of bcl-2 protein expression in aggressive non-Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA).

J Diebold, P. Gaulard, G. Salles, 1996, Blood.

Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma.

T. Molina, B. Coiffier, H. Tilly, 2003, Blood.

lymphomas Prognostic significance of survivin expression in diffuse large B-cell

T. Molina, P. Gaulard, G. Salles, 2013 .

Doxorubicin-containing regimen with or without interferon alfa-2b for advanced follicular lymphomas: final analysis of survival and toxicity in the Groupe d'Etude des Lymphomes Folliculaires 86 Trial.

J. Rossi, B. Coiffier, R. Bouabdallah, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment of acute lymphoblastic leukemia French protocol Fralle 83-87.

A. Baruchel, G. Leverger, É. Lepage, 1992, Leukemia.

Duration and intensity of maintenance chemotherapy in acute lymphoblastic leukaemia: overview of 42 trials involving 12 000 randomised children

C. Pui, R. Peto, J. Peto, 1996, The Lancet.

Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte.

P. Gaulard, G. Salles, B. Coiffier, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Tumour necrosis factor-alpha, interleukin-1 beta and interleukin-6 in patients with renal cell carcinoma.

É. Lepage, J. Wautier, J. Cabane, 1994, European journal of cancer.

Prognosis of patients with advanced hodgkin's disease

F. Berger, É. Lepage, P. Lederlin, 1997, Cancer.

Adult acute lymphoblastic leukemia: a multicentric randomized trial testing bone marrow transplantation as postremission therapy. The French Group on Therapy for Adult Acute Lymphoblastic Leukemia.

C. Gisselbrecht, C. Sebban, É. Lepage, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adult Acute Lymphoblastic Leukemia — Results of the French AALL 87 Protocol with Different Strategies of Postremission Therapy

H. Dombret, A. Delannoy, C. Sebban, 1994 .

Prognostic significance of received relative dose intensity in non-Hodgkin's lymphoma patients: application to LNH-87 protocol. The GELA. (Groupe d'Etude des Lymphomes de l'Adulte).

C Sebban, B. Coiffier, H. Tilly, 1993, Annals of oncology : official journal of the European Society for Medical Oncology.

Quality-of-life-adjusted survival analysis of interferon alfa-2b treatment for advanced follicular lymphoma: an aid to clinical decision making.

R. Gelber, A. Goldhirsch, C. Gisselbrecht, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

l'Adulte (GELA) non- Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de Prognostic significance of bcl-2 protein expression in aggressive

P. Gaulard, G. Salles, J. Diebold, 2002 .

Prognostic Significance of bcl-2 Protein Expression in Aggressive Non-Hodgkin's Lymphoma

P. Gaulard, G. Salles, J. Diebold, 1996 .

Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate-grade and high-grade non-Hodgkin's lymphoma in first complete remission: a study of 464 patients. Groupe d'Etude des Lymphomes de l'Adulte.

B. Coiffier, H. Tilly, C. Gisselbrecht, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Immunophenotype of Adult Acute Lymphoblastic Leukemia, Clinical Parameters, and Outcome: An Analysis of a Prospective Trial Including 562 Tested Patients (LALA87)

F. Sigaux, C. Sebban, M. Béné, 1994 .

Adult acute lymphocytic leukemia study testing chemotherapy and autologous and allogeneic transplantation. A follow-up report of the French protocol LALA 87.

C. Sebban, É. Lepage, J. Reiffers, 2000, Hematology/oncology clinics of North America.

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.

Pierre Morel, Raoul Herbrecht, Felix Reyes, 2002, The New England journal of medicine.

standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma Intensive conventional chemotherapy (ACVBP regimen) compared with

T. Molina, B. Coiffier, H. Tilly, 2009 .

ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma.

T. Molina, B. Coiffier, H. Tilly, 2005, The New England journal of medicine.

TiA1 in advanced-stage classical Hodgkin’s lymphoma: no prognostic impact for positive tumour cells or number of cytotoxic cells

P. Gaulard, F. Berger, É. Lepage, 2004, Virchows Archiv.

Assessing the Cox model assumption as a statistical tool for classifying lymphomas.

B. Coiffier, H. Dombret, F. Morschhauser, 2001, The hematology journal : the official journal of the European Haematology Association.

Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol--a groupe d'Etude des lymphomes de l'Adulte study.

P. Gaulard, G. Salles, B. Coiffier, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparison of chemotherapy to radiotherapy as consolidation of complete or good partial response after six cycles of chemotherapy for patients with advanced Hodgkin's disease: results of the groupe d'études des lymphomes de l'Adulte H89 trial.

F. Berger, C. Sebban, É. Lepage, 2000, Blood.

Placebo-controlled phase III study of lenograstim (glycosylated recombinant human granulocyte colony-stimulating factor) in aggressive non-Hodgkin's lymphoma: factors influencing chemotherapy administration. Groupe d'Etude des Lymphomes de l'Adulte.

B. Coiffier, H. Tilly, C. Gisselbrecht, 1997, Leukemia & lymphoma.

Prognosis and treatment of lymphoblastic lymphoma in adults: a report on 80 patients.

C. Gisselbrecht, É. Lepage, P. Morel, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The significance of a residual mediastinal mass following treatment for aggressive non-Hodgkin's lymphomas.

C. Gisselbrecht, É. Lepage, J. Trédaniel, 1992, The European respiratory journal.

Beneficial effect of highly active antiretroviral therapy on the prognosis of AIDS-related systemic non-Hodgkin lymphomas.

É. Lepage, Y. Lévy, C. Goujard, 2005, AIDS research and human retroviruses.

Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d'Etude des Lymphomes Folliculaires. Groupe d'Etude des Lymphomes de l'Adulte.

H. Tilly, N. Brousse, É. Lepage, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Recombinant interferon alfa-2b combined with a regimen containing doxorubicin in patients with advanced follicular lymphoma. Groupe d'Etude des Lymphomes de l'Adulte.

B. Coiffier, C. Gisselbrecht, N. Brousse, 1993, The New England journal of medicine.

[18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome.

Emmanuel Itti, Michel Meignan, Felix Reyes, 2005, Blood.

CD10 expression in diffuse large B-cell lymphomas does not influence survival

T. Molina, P. Gaulard, J. Diebold, 2004, Virchows Archiv.

H. Tilly, É. Lepage, C. Haioun, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

Tandem autotransplant as first-line consolidative treatment in poor-risk aggressive lymphoma: a pilot study of 36 patients.

P. Gaulard, B. Quesnel, C. Gisselbrecht, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

Allogeneic bone marrow transplantation in adult acute lymphoblastic leukemia in first complete remission: a comparative study. French Group of Therapy of Adult Acute Lymphoblastic Leukemia.

C. Sebban, É. Lepage, J. Reiffers, 1994, Journal of Clinical Oncology.

Bone marrow with diffuse tumor infiltration in patients with lymphoproliferative diseases: dynamic gadolinium-enhanced MR imaging.

P. Gaulard, A. Rahmouni, É. Lepage, 2003, Radiology.

Quality of life-adjusted survival analysis of high-dose therapy with autologous bone marrow transplantation versus sequential chemotherapy for patients with aggressive lymphoma in first complete remission. Groupe d'Etude les Lymphomes de l'Adulte (GELA).

C Sebban, G. Salles, R. Bouabdallah, 2000, Blood.

Analysis of prognostic factors after the first relapse of Hodgkin's disease in 187 patients

É. Lepage, O. Reman, J. Gabarre, 1996, Cancer.

Health, economic, and quality-of-life effects of erythropoietin and granulocyte colony-stimulating factor for the treatment of myelodysplastic syndromes: a randomized, controlled trial.

H. Dombret, A. Stamatoullas, A. Vekhoff, 2004, Blood.

Allogeneic and Autologous Bone Marrow Transplantation and Chemotherapy in First Remission of Adult Acute Lymphoblastic Leukemia: Results of the LALA 87 Trial of the French Group

É. Lepage, J. Reiffers, J. Vernant, 1997 .

Prognostic value of early response to chemotherapy assessed by the day 15 bone marrow aspiration in adult acute lymphoblastic leukemia: a prospective analysis of 437 cases and its application for designing induction chemotherapy trials.

C. Sebban, G. Browman, É. Lepage, 1995, Leukemia research.

Prognostic factors in large-cell lymphomas.

B. Coiffier, É. Lepage, 1993, Leukemia & lymphoma.

Treatment of relapsed and refractory Hodgkin's disease with high dose chemotherapy and autologous bone marrow transplantation.

A. Baruchel, C. Gisselbrecht, M. Boiron, 1991, Nouvelle revue francaise d'hematologie.

[Autografts of blood cells at various stages].

G. Leverger, M. Boiron, É. Lepage, 1988, Nouvelle revue francaise d'hematologie.

Is the volume-outcome relation still an issue in the era of PCI with systematic stenting? Results of the greater Paris area PCI registry.

M. Morice, É. Lepage, C. Spaulding, 2006, European heart journal.

Were less disabled patients the most affected by 2003 heat wave in nursing homes in Paris, France?

É. Lepage, A. Spira, F. Canouï-Poitrine, 2005, Journal of public health.

Treatment of low‐grade non‐Hodgkin's lymphomas: Assessment of doxorubicin in a controlled trial

B. Coiffier, C. Gisselbrecht, M. Boiron, 1990, Hematological oncology.

Erratum to: Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study

J. le Gall, C. Brun-Buisson, R. Moreno, 2002, Intensive Care Medicine.

Outcome is not improved by the use of alternating chemotherapy in elderly patients with aggressive lymphoma.

P. Gaulard, C. Gisselbrecht, É. Lepage, 2001, The hematology journal : the official journal of the European Haematology Association.

Human immunodeficiency virus-related lymphoma: relation between clinical features and histologic subtypes.

L. Xerri, É. Oksenhendler, C. Katlama, 2001, The American journal of medicine.

Prevalence, etiologies and outcome of the acute respiratory distress syndrome among hypoxemic ventilated patients

M. Wysocki, L. Brochard, F. Lemaire, 1999, Intensive Care Medicine.

High cost factors for leukaemia and lymphoma patients: a new analysis of costs within these diagnosis related groups.

L Dusserre, C Quantin, P Brunet-Lecomte, 1999, Journal of epidemiology and community health.

Aggressive non Hodgkin lymphoma in the elderly. A retrospective study of 72 patients with clinical features and treatment.

C. Gisselbrecht, M. Boiron, É. Lepage, 1990, Nouvelle revue francaise d'hematologie.

Remission induction and maintenance modalities in acute myeloid leukemia: a multicenter randomized study.

G. Leverger, M. Marty, M. Boiron, 1987, Haematology and blood transfusion.

Hodgkin's disease, clinical stages I, II A-B and IIIA. Results of brief chemotherapy followed by irradiation.

M. Marty, É. Lepage, P. Brice, 1992, Nouvelle revue francaise d'hematologie.

Alternating Chemotherapy Does Not Improve Results in Poor-prognosis Aggressive Lymphomas - Lnh87 Protocol Group-3 - a Gela Study

P. Gaulard, B. Coiffier, H. Tilly, 1993 .

Chemotherapy combined with zidovudine and GM-CSF in human immunodeficiency virus-related non-Hodgkin's lymphoma.

R. Tubiana, C. Sebban, É. Lepage, 1995, Annals of oncology : official journal of the European Society for Medical Oncology.

Treatment of Adult Acute Lymphoblastic Leukemia Long Term Results of a Prospective Study: LALA 87

A. Delannoy, C. Sebban, É. Lepage, 2001 .

Noninvasive versus conventional mechanical ventilation. An epidemiologic survey.

M. Wysocki, L. Brochard, É. Lepage, 2001, American journal of respiratory and critical care medicine.

Diagnostic value of dominant T-cell clones in peripheral blood in 363 patients presenting consecutively with a clinical suspicion of cutaneous lymphoma

É. Lepage, L. Laroche, M. Bagot, 2000 .

CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC only. TRIALS

É. Lepage, L. Laroche, M. Bagot, 2004 .

Treatment of acute hypoxemic nonhypercapnic respiratory insufficiency with continuous positive airway pressure delivered by a face mask: A randomized controlled trial.

F Lemaire, E L'Her, M Antonelli, 2000, JAMA.

Is Early Response to Chemotherapy a Useful Prognostic Factor in Adult Acute Lymphoblastic Leukemia

C. Sebban, É. Lepage, X. Troussard, 1994 .

Human immunodeficiency virus-related lymphoma treatment with intensive combination chemotherapy. French-Italian Cooperative Group.

B. Coiffier, É. Oksenhendler, C. Gisselbrecht, 1993, The American journal of medicine.

Measuring performance in health care: case-mix adjustment by boosted decision trees

Éric Lepage, Anke Neumann, Josiane Holstein, 2004, Artif. Intell. Medicine.

Prognosis of patients with advanced hodgkin's disease

F. Berger, É. Lepage, P. Lederlin, 1997, Cancer.